Unresectable Gallbladder Cancer Completed Phase 2 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0028792 (Unresectable Gallbladder Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01229111Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary CancersTreatment